首页 | 本学科首页   官方微博 | 高级检索  
检索        

维拉帕米缓释片与硝苯地平或维拉帕米治疗高血压病疗效比较
引用本文:包森和,谭志元,刘志琴.维拉帕米缓释片与硝苯地平或维拉帕米治疗高血压病疗效比较[J].中国新药与临床杂志,1995(3).
作者姓名:包森和  谭志元  刘志琴
作者单位:浙江省泰顺县人民医院,广西壮族自治区柳州市工人医院,浙江省云和县中医医院
摘    要:目的:比较维拉帕米缓释片与硝苯地平或维拉帕米治疗高血压的疗效。方法:维拉帕米缓释片(SRVT)组34例(男性21例,女性13例,年龄58±s11a),剂量120-240mg,po,qd;硝苯地平(Nif)组38例(男性21例,女性17例,年龄60±11a),剂量10-20mg,po,tid;维拉帕米(Ver)组36例(男性22例,女性14例,年龄58±11a),剂量40-80mg,po,tid;3组疗程均为30d。结果:SRVT,Nif及Ver均有非常显著降压效果(P<0.01),总有效率依次为94%,95%及94%。结论:3组降压疗效相似,但Nif组不良反应大于另2种药物。

关 键 词:维拉帕米,硝苯地平,高血压,迟效制剂

Comparioson of therapeutic effects of slow-release verspamil tablet and nifedipine or verapamil on hypertension
BAO Sen-He.Comparioson of therapeutic effects of slow-release verspamil tablet and nifedipine or verapamil on hypertension[J].Chinese Journal of New Drugs and Clinical Remedies,1995(3).
Authors:BAO Sen-He
Abstract:TO Compare the efficacies of slow-release verapamil tablet(SRVT)and nifedipine(Nif)or verapamil(Ver)on hypertension. METHODS:SRVT group of 34 patients(M21,F13;age 58±s11a)received 120-240 mg,po,qd;Nif group of 38 patients(M 21,F 17;age 60±11a) received 10-20 mg,po,tid;Ver group of 36 patients(M 22,F 14;age 58±11 a) received 40-80 mg, po,tid course of treatment 30 d.RESULTS:SRVT,Nif and Ver all had remarkable antihypertensive effect(P<0.01),the total response rates were 94%,95%,and 94%,respectively.CONCLUSION:The antihypertensive effect of SRVT,Nif,and Ver are similar,but Nif shows more adverse reactions than SRVT and Ver.
Keywords:verapamil  nifedipine  hypertension  delayed-action preparations  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号